KRRO.NASDAQKorro Bio, INC

SCHEDULE: FMR LLC Reports 0.4% Stake in Korro Bio Inc

Sentiment:

Beneficial Ownership Report


FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a beneficial ownership of 0.4% in Korro Bio Inc's common stock as of December 31, 2025.

Summary

  • FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in KORRO BIO INC.
  • The filing reports beneficial ownership of 37,857 shares of KORRO BIO INC's common stock as of December 31, 2025.
  • This aggregate amount represents 0.4% of the class of KORRO BIO INC's common stock.
  • FMR LLC holds sole voting power over 33,257 shares and sole dispositive power over 37,857 shares.
  • Abigail P. Johnson holds sole dispositive power over 37,857 shares, with no sole or shared voting power directly attributed to her in this filing.
  • Abigail P. Johnson is identified as a Director, Chairman, and Chief Executive Officer of FMR LLC, with the Johnson family being predominant owners of FMR LLC.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a routine disclosure of beneficial ownership by an institutional investor and does not contain information that would typically alter the investment thesis for Korro Bio Inc.

Positives

  • NA

Negatives

  • NA

Risks

  • NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings provide transparency into institutional ownership, indicating that FMR LLC, a major investment management firm, maintains a minor stake in Korro Bio Inc. This type of filing is routine for large asset managers and typically reflects portfolio adjustments rather than a strategic move to influence company control.

Stakeholder Impact

  • Shareholders: Provides transparency regarding institutional ownership, confirming FMR LLC's continued, albeit minor, stake in the company. No significant change in control or strategic direction is implied by this filing.

Key Dates

DateDescription
2023-01-03Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries.
2023-01-10Date of Schedule 13G filing by FMR LLC where Power of Attorney (Exhibit 24) was incorporated by reference.
2023-01-26Effective date of Power of Attorney for Abigail P. Johnson.
2023-01-31Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney (Exhibit 24) was incorporated by reference.
2025-12-31Date of event which requires filing of this statement (beneficial ownership snapshot date).
2026-02-04Signature date of the Schedule 13G Amendment No. 2 filing.

Keywords

Korro Bio Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Biotechnology, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.